Pfizer Ltd. has informed the Exchange that the Board of Directors of the Company, at its meeting held on September 26, 2009, has, subject to receipt of all requisite consents and approvals from statutory and regulatory authorities pursuant to the applicable provisions of the Companies Act, 1956, approved the Scheme of Amalgamation of Duchem Laboratories Limited (wholly owned subsidiary of Pfizer Limited) and Pfizer Limited. The Scheme is proposed to be effective December 1, 2008. The Transferor Company being the wholly owned subsidiary of Pfizer Limited, no consideration shall be payable to the Transferor Company or its shareholders pursuant to the Amalgamation and the shares held by Pfizer Limited and its nominees in the Transferor Company shall stand cancelled.
| NIFTY 
